Theranostic doxorubicin encapsulated FeAu alloy@metal-organic framework nanostructures enable magnetic hyperthermia and medical imaging in oral carcinoma

• DOI: 10.1016/j.nano.2023.102652
• Publication Date: 2023-01-07T01:27:30Z
• Authors: Udesh Dhawan; Ching-Li Tseng; Ping-Hsuan Wu; Mei-Yi Liao; Huey-Yuan Wang; Kevin C.-W. Wu; Ren-Jei Chung
• Keywords: Diagnostic Imaging; 0301 basic medicine; 0303 health sciences; Magnetic Phenomena; Carcinoma; Hyperthermia, Induced; Theranostic Nanomedicine; 3. Good health; Nanostructures; Mice; 03 medical and health sciences; Doxorubicin; Animals; Mouth Neoplasms; Precision Medicine; Metal-Organic Frameworks

Metal-organic frameworks (MOFs) have emerged as attractive candidates in cancer theranostics due to their ability to envelop magnetic nanoparticles, resulting in reduced cytotoxicity and high porosity, enabling chemodrug encapsulation. Here, FeAu alloy nanoparticles (FeAu NPs) are synthesized and coated with MIL-100(Fe) MOFs to fabricate FeAu@MOF nanostructures. We encapsulated Doxorubicin within the nanostructures and evaluated the suitability of this platform for medical imaging and cancer theranostics. FeAu@MOF nanostructures (FeAu@MIL-100(Fe)) exhibited superparamagnetism, magnetic hyperthermia behavior and displayed DOX encapsulation and release efficiency of 69.95 % and 97.19 %, respectively, when stimulated with alternating magnetic field (AMF). In-vitro experiments showed that AMF-induced hyperthermia resulted in 90 % HSC-3 oral squamous carcinoma cell death, indicating application in cancer theranostics. Finally, in an in-vivo mouse model, FeAu@MOF nanostructures improved image contrast, reduced tumor volume by 30-fold and tumor weight by 10-fold, which translated to enhancement in cumulative survival, highlighting the prospect of this platform for oral cancer treatment.